Delivery Order 36C25724D0080-36C25724N0432

Award Date 9/18/24
Potential Completion Date 9/17/25
Potential Value $982K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order awarded to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7). The contract, valued at $440,764.00, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine diagnostic services at VA medical centers. The award is designated as a total...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $1,395,620.34, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine diagnostic services at VA medical centers. The contract is not set aside and was awarded on February 28, 2020, with...
This federal contract award is to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate. The contract, valued at $216,261.99, is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). RLS (USA) Inc. operates 31 radiopharmacy facilities across 18...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $607,676.91 firm fixed price delivery order contract to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, and technetium-99m, to support nuclear medicine services at the Milwaukee VA Medical Center. This delivery order contract is likely part of a...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT) to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The award, Contract ID 36C24224D0048|36C24225N0194, has a ceiling value of $6,874.38 and is a Firm Fixed Price Delivery Order with an ultimate completion date of...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to RLS USA Inc., a foreign-owned, for-profit radiopharmacy, to provide various radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and other medical isotopes. The contract has a total potential value of $2,930,951.59 and includes a base year plus four one-year option periods, with deliveries to the VA Long Beach Healthcare System. The...
This firm-fixed price federal contract award, valued at $425,794.77, was issued by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine diagnostic procedures at VA medical centers and military treatment facilities over a 6-month period ending in July 2024. RLS (USA) Inc. operates a nationwide network of 31 radiopharmacy facilities,...
This firm-fixed-price contract with a ceiling value of $852,160.60 was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to provide radiopharmaceuticals to the VA Long Beach Healthcare System in Long Beach, California. The contract has a base term of one year and four one-year option periods, with a total potential performance period through November 30, 2025. The contract was awarded under an unrestricted solicitation that...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 21 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $378,281.55, is for the delivery of radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and the Defense Health Agency...
  • 36C25724D0080
    Indefinite Delivery Contract
  • 36C25724D0080-36C25724N0432
    Delivery Order

This firm-fixed-price delivery order contract was awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17. The contract is for the provision of radiopharmaceuticals, including gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military personnel.

The contract has a ceiling value of $981,644.58 and a performance period ending on September 17, 2025. RLS (USA) Inc. holds several federal contract Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency to facilitate the efficient procurement of its radiopharmaceutical products. These IDVs have potential values ranging from hundreds of thousands to nearly two million dollars, with performance periods typically lasting three to five years. The contract was not set aside for any specific business category.

Generated 8/13/24, 11:44 AM